Avalo Therapeutics, Inc. (AVTX)
16.37
+0.61
(+3.87%)
USD |
NASDAQ |
Jan 22, 16:00
16.37
0.00 (0.00%)
After-Hours: 19:57
Avalo Therapeutics Market Cap: 296.85M for Jan. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rocket Pharmaceuticals, Inc. | 409.08M |
| NovaBay Pharmaceuticals, Inc. | 707.83M |
| Palatin Technologies, Inc. | 15.58M |
| Theriva Biologics, Inc. | 6.863M |
| Oragenics, Inc. | 0.7734M |
Market Cap Related Metrics
| PS Ratio | 976.60 |
| Price to Book Value | 3.243 |
| Price | 16.37 |
| Earnings Yield | -53.33% |